Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CVS Caremark
Pharma
CVS will cover Eli Lilly obesity products Zepbound and Foundayo
CVS will restore coverage to obesity products from Eli Lilly, allowing patients to gain access to the drugs through their existing insurance.
Kevin Dunleavy
May 28, 2026 11:20am
Lilly blows out tirzepatide sales expectations, raises guidance
Oct 30, 2025 10:39am
CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now
Aug 21, 2025 3:02pm
Novo's Wegovy secures preferred obesity spot on CVS formulary
May 1, 2025 2:39pm
CVS to replace branded Humira with biosims on some formularies
Jan 4, 2024 11:38am
Civica Rx draws $50M from California to produce low-cost insulin
Mar 20, 2023 11:45am
